ANTI-ANGIOGENIC THERAPY IN PATIENTS WITH PATHOLOGIC MYOPIA AND CHOROIDAL NEOVASCULARIZATION

Purpose of the study: to study the efficacy and safety of Ranibizumab in patients with pathologic myopia and choroidal neovascularization (CNV). 22 patients (22 eyes) with myopic CNV were included in the study. Mean age was 54.0 ± 14.4 years, axial length -28.25± 1.9 mm,follow-up-from 12 to 59 month...

Full description

Saved in:
Bibliographic Details
Main Authors: S. A. Korotkikh, E. V. Bobykin, G. V. Zhiborkin, A. Y. Anashkin, A. V. Berezin
Format: article
Language:RU
Published: Scientific Сentre for Family Health and Human Reproduction Problems 2016
Subjects:
Q
Online Access:https://doaj.org/article/113add6fa8974e6a8fda12e9e7207145
Tags: Add Tag
No Tags, Be the first to tag this record!